Materias dentro de su búsqueda.
Mostrando 1,261 - 1,280 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.32s Limitar resultados
  1. 1261
    “…Development of molecular markers such as HER2 and Survivin may provide useful information on diagnosis and prognosis in UN of bladder. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Survivin and Her2 Expressions in Different Grades of Urothelial Neoplasms of Urinary Bladder
  2. 1262
    por Schlam, Ilana, Swain, Sandra M.
    Publicado 2021
    “…Human epidermal growth factor receptor 2 (HER2) positive breast cancer accounts for 20–25% of all breast cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
  3. 1263
    “…AIM: We explore HER3 expression in lung adenocarcinoma (adeno-NSCLC) and identify potential mechanisms of HER3 expression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER3 expression and MEK activation in non-small-cell lung carcinoma
  4. 1264
    “…Immunohistochemical (IHC) staining for EGFR and HER-2/NEU was performed on all the selected cases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC)
  5. 1265
    “…Pyrotinib (PYR) is a pan-HER kinase inhibitor that inhibits signaling via the RAS/RAF/MEK/MAPK and PI3K/AKT pathways. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
  6. 1266
    por Xu, Zizhong, Hu, Yating, Yu, Zhaohui
    Publicado 2021
    “…Caspase-3 activity was assessed using a commercial kit. HER2 and TRAIL expression levels were determined by western blotting. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of the ACY-1 gene on HER2 and TRAIL expression in rectal carcinoma
  7. 1267
    “…We also provide recommendations for future studies with HER2 aptamers to target HER2(+) BC.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach
  8. 1268
    “…In vitro binding was evaluated in HER2-overexpressing (BT474, SKBR3) and HER2-negative (MCF7) cell lines. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer
  9. 1269
    “…The receptor tyrosine kinase HER2 acts as oncogenic driver in numerous cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
  10. 1270
    “…The percentage of HER2-positive tumors was 13.4%, predominantly in men. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Her2-Positive and Microsatellite Instability Status in Gastric Cancer—Clinicopathological Implications
  11. 1271
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Second line of treatment for HER2-positive gastric cancer: an evolving issue
  12. 1272
    por Kahraman, Seda, Yalcin, Suayib
    Publicado 2021
    “…Despite these promising avenues, the optimal management of HER-2 positive GC still requires further development.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
  13. 1273
    por Mukundan, Ramakrishnan
    Publicado 2019
    “…This paper explores in detail various types of feature measurements that are suitable for the automated scoring of human epidermal growth factor receptor 2 (HER2) in histology slides. These are intensity features known as characteristic curves, texture features in the form of uniform local binary patterns (ULBPs), morphological features specifying connectivity of regions, and first-order statistical features of the overall intensity distribution. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Analysis of Image Feature Characteristics for Automated Scoring of HER2 in Histology Slides †
  14. 1274
    “…Tissues scoring 0 to 2+ were defined as HER2 negative, whereas those scoring 3+ were regarded as HER2-positive. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
  15. 1275
    por Mayer, Erica L.
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer
  16. 1276
    “…PURPOSE OF REVIEW: HER2-targeted therapies have led to improved clinical outcomes in early and advanced breast cancer (BC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
  17. 1277
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Copper Tolerance and Accumulation on Pelargonium graveolens L’Hér. Grown in Hydroponic Culture
  18. 1278
    “…The crosstalk between PRLR and HER2, where PRL induces HER2 signaling can be an alternative route for ERα activation to induce transcription of PRLR and other ER target genes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
  19. 1279
    “…Even though gene amplification or protein overexpression occurs in approximately one-fifth of all breast cancers, the discovery of HER2 has, nevertheless, had profound implications for the disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
  20. 1280
    “…About a half of HER2-negative breast cancer (BC) show HER2-low expression that can be targeted by new antibody-drug conjugates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evolution of HER2-low expression from primary to recurrent breast cancer
Herramientas de búsqueda: RSS